Invention Grant
US08420658B2 Use of Carboxyamidotriazole (CAI) orotate in macular degeneration
有权
使用羧酰胺三唑（CAI）乳酸在黄斑变性
- Patent Title: Use of Carboxyamidotriazole (CAI) orotate in macular degeneration
- Patent Title (中): 使用羧酰胺三唑（CAI）乳酸在黄斑变性
-
Application No.: US12800839Application Date: 2010-05-24
-
Publication No.: US08420658B2Publication Date: 2013-04-16
- Inventor: Rashida A Karmali
- Applicant: Rashida A Karmali
- Applicant Address: US NY New York
- Assignee: Tactical Therapeutics Inc
- Current Assignee: Tactical Therapeutics Inc
- Current Assignee Address: US NY New York
- Agent Rashida A. Karmali
- Main IPC: A61K31/505
- IPC: A61K31/505
Abstract:
Method and composition of Carboxyamidotriazole orotate for treating age-related macular degeneration and other angiogenesis-dependent diseases.
Public/Granted literature
- US20100298363A1 Use of carboxyamidotriazole (CAI) orotate in macular degeneration Public/Granted day:2010-11-25
Information query
